Delivery Order SPE2DB20D2001-SPE2DB23FM53D

Award Date 5/11/23
Potential Completion Date 5/12/23
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $8,356.68 for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through September 30, 2024. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order valued at $7,028.80 with a completion date of January 31, 2025. The award, from the Defense Logistics Agency (DLA), is for the provision of 4567102555 TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order worth $5,831.12 for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 1, 2023. The contract is a Firm Fixed Price arrangement with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order worth $5,802.36 for the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The award was made on December 16, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with a performance period through December 17, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $2,177.10 for the supply of the pharmaceutical product TRULICITY 3 MG/0.5 ML PEN 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $7,910.63 for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,953.04 firm fixed-price delivery order is for TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a completion date of May 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award of $1,741.68 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML. The contract has a firm fixed price pricing type and an ultimate completion date of June 28, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $1,161.12 Firm Fixed Price Delivery Order for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 4, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,031.96, is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of September 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB23FM53D
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order worth $3,483.36 for the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The award was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 12, 2023. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 2/27/25, 12:19 PM